BIOW_LYSSH
ID BIOW_LYSSH Reviewed; 245 AA.
AC P22822;
DT 01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT 01-AUG-1991, sequence version 1.
DT 03-AUG-2022, entry version 87.
DE RecName: Full=6-carboxyhexanoate--CoA ligase;
DE EC=6.2.1.14;
DE AltName: Full=Pimeloyl-CoA synthase;
GN Name=bioW;
OS Lysinibacillus sphaericus (Bacillus sphaericus).
OC Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Lysinibacillus.
OX NCBI_TaxID=1421;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=ATCC 10208 / DSM 5019 / NBRC 3525 / NCIMB 11935 / NRS 966 / 1911;
RX PubMed=2110099; DOI=10.1016/0378-1119(90)90496-e;
RA Gloeckler R., Ohsawa I., Speck D., Ledoux C., Bernard S., Zinsius M.,
RA Villeval D., Kisou T., Kamogawa K., Lemoine Y.;
RT "Cloning and characterization of the Bacillus sphaericus genes controlling
RT the bioconversion of pimelate into dethiobiotin.";
RL Gene 87:63-70(1990).
RN [2]
RP PROTEIN SEQUENCE OF 1-15, FUNCTION AS A PIMELOYL-COA SYNTHASE, CATALYTIC
RP ACTIVITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE
RP SPECIFICITY, COFACTOR, AND SUBUNIT.
RC STRAIN=ATCC 10208 / DSM 5019 / NBRC 3525 / NCIMB 11935 / NRS 966 / 1911;
RX PubMed=1445232; DOI=10.1042/bj2870685;
RA Ploux O., Soularue P., Marquet A., Gloeckler R., Lemoine Y.;
RT "Investigation of the first step of biotin biosynthesis in Bacillus
RT sphaericus. Purification and characterization of the pimeloyl-CoA synthase,
RT and uptake of pimelate.";
RL Biochem. J. 287:685-690(1992).
CC -!- FUNCTION: Catalyzes the transformation of pimelate into pimeloyl-CoA
CC with concomitant hydrolysis of ATP to AMP.
CC {ECO:0000269|PubMed:1445232}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP + CoA + heptanedioate = 6-carboxyhexanoyl-CoA + AMP +
CC diphosphate; Xref=Rhea:RHEA:14781, ChEBI:CHEBI:30616,
CC ChEBI:CHEBI:33019, ChEBI:CHEBI:36165, ChEBI:CHEBI:57287,
CC ChEBI:CHEBI:57360, ChEBI:CHEBI:456215; EC=6.2.1.14;
CC Evidence={ECO:0000269|PubMed:1445232};
CC -!- COFACTOR:
CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC -!- ACTIVITY REGULATION: Inhibited by magnesium above 10 mM and metal
CC chelators such as 1, 10-phenanthroline and EDTA.
CC {ECO:0000269|PubMed:1445232}.
CC -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC Kinetic parameters:
CC KM=33 uM for CoASH {ECO:0000269|PubMed:1445232};
CC KM=145 uM for pimelate {ECO:0000269|PubMed:1445232};
CC KM=170 uM for ATP {ECO:0000269|PubMed:1445232};
CC pH dependence:
CC Optimum pH is between 8.5 and 9.0. {ECO:0000269|PubMed:1445232};
CC -!- PATHWAY: Metabolic intermediate metabolism; pimeloyl-CoA biosynthesis;
CC pimeloyl-CoA from pimelate: step 1/1.
CC -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:1445232}.
CC -!- SIMILARITY: Belongs to the BioW family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; M29291; AAA22270.1; -; Genomic_DNA.
DR PIR; JQ0511; JQ0511.
DR RefSeq; WP_029747250.1; NZ_UFSZ01000001.1.
DR AlphaFoldDB; P22822; -.
DR SMR; P22822; -.
DR GeneID; 48278543; -.
DR BioCyc; MetaCyc:MON-14017; -.
DR UniPathway; UPA00999; UER00351.
DR GO; GO:0042410; F:6-carboxyhexanoate-CoA ligase activity; IDA:UniProtKB.
DR GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-UniRule.
DR GO; GO:0009102; P:biotin biosynthetic process; IDA:UniProtKB.
DR HAMAP; MF_00668; BioW; 1.
DR InterPro; IPR005499; BioW.
DR Pfam; PF03744; BioW; 1.
DR TIGRFAMs; TIGR01204; bioW; 1.
PE 1: Evidence at protein level;
KW ATP-binding; Biotin biosynthesis; Direct protein sequencing; Ligase;
KW Magnesium; Nucleotide-binding.
FT CHAIN 1..245
FT /note="6-carboxyhexanoate--CoA ligase"
FT /id="PRO_0000191015"
FT CONFLICT 3..4
FT /note="ET -> I (in Ref. 2; AA sequence)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 245 AA; 27591 MW; B1407C8D70F570EC CRC64;
MLETCYSIRM RAAEKNLEGG EKHISGGERI GSEFQIEPIV KQLLNKARNH SRGDADFIQI
TVEKLTGDQI LYMPPLEITT IDESSIERAH KEARSILTSV GVSKQAQNVA FHLLASNQNL
RGAILLHSQT GLRLDNRGLK GVRVSRIDWQ DADVGYNERV REALALATKV ANSPYTIAEL
CWSDDPEYVT GYVSNHEIGY VRITPLKREG CESGGRIFFV SDEVELESYI HYLEREPILI
RGHLK